AAM Buy American Fact Sheet | Association for Accessible Medicines
COVID-19 and AAM - FAQ's and resources from the U.S. generics and biosimilars industry.

AAM Buy American Fact Sheet

New “Buy American” requirements on medicines would limit patient access to affordable medicines and increase the risk of drug shortages during the COVID-19 pandemic.

  • Developers of generic and biosimilar medicines support diversification of the pharmaceutical supply chain — and incentives to increase manufacturing in the United States — but we must not hinder our response to the COVID-19 emergency.
  • Changes to the “Buy American” provisions should not limit the ability of the U.S. government to provide medicines to veterans, soldiers and other patients during or after this time of national emergency.

Download Fact Sheet

View Letter to the President

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.